Pankaj Arora, MD - Nutrition Obesity ...

Dr. Pankaj Arora, MD

Claim this profile

University of Alabama at Birmingham

Studies Obesity
Studies Cardiovascular Disease
6 reported clinical trials
10 drugs studied

Affiliated Hospitals

Image of trial facility.

University Of Alabama At Birmingham

Clinical Trials Pankaj Arora, MD is currently running

Image of trial facility.

Sacubitril-Valsartan

for High Blood Pressure

Obese individuals have a higher prevalence of nocturnal hypertension and non-dipping blood pressure (BP). These conditions are associated with an increased risk of cardiovascular (CV) events and death. Natriuretic Peptides (NPs) are hormones produced by the heart which directly regulate BP by causing dilation of blood vessels and by removing sodium and water from the body. NPs have a 24-hour day-night rhythm and this controls the day-night rhythm of BP as well. The NP-BP rhythm relationship is broken down in obese individuals. Obese individuals also have lower circulating NP levels. Lower circulating levels of NPs and elevated renin hormone (a part of the Renin-Angiotensin-Aldosterone System \[RAAS\]) at nighttime may contribute to the high nocturnal blood pressure in obese individuals which puts them at a higher risk of developing CV events. This current study seeks to determine the biological implications of chronopharmacology for synchronizing NP-RAAS-based blood pressure therapy with the physiological diurnal rhythms to restore the normal diurnal rhythm of blood pressure in obese individuals.

Recruiting

1 award

Phase 2 & 3

3 criteria

Image of trial facility.

Sacubitril/Valsartan

for Metabolic Health in Black Individuals

This trial tests if sacubitril/valsartan can improve insulin sensitivity and energy use in Black individuals by increasing heart hormone levels. Black individuals are targeted because they often have lower levels of these hormones, leading to higher risks of diabetes. Valsartan has been studied for its potential to improve insulin sensitivity and β-cell function in various populations, including those with impaired glucose metabolism.

Recruiting

1 award

Phase 2

3 criteria

More about Pankaj Arora, MD

Clinical Trial Related

1 year of experience running clinical trials · Led 6 trials as a Principal Investigator · 4 Active Clinical Trials

Treatments Pankaj Arora, MD has experience with

  • Sacubitril
  • Valsartan
  • Vericiguat
  • Exercise Capacity VO2 Max Determination
  • Exercise Challenge
  • Glucose Challenge

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Pankaj Arora, MD specialize in?

Is Pankaj Arora, MD currently recruiting for clinical trials?

Are there any treatments that Pankaj Arora, MD has studied deeply?

What is the best way to schedule an appointment with Pankaj Arora, MD?

What is the office address of Pankaj Arora, MD?

Is there any support for travel costs?